Canaccord Genuity Maintains Buy on CeriBell, Lowers Price Target to $25

Benzinga Newsdesk www.benzinga.com Negative 65.5%

Neg 65.5% Neu 0% Pos 0%

Canaccord Genuity analyst William Plovanic maintains CeriBell (NASDAQ:CBLL) with a Buy and lowers the price target from $28 to $25.